Rick Simpson Oil (RSO) in Putnam County, Illinois: The Complete Guide by OilWell Cannabis

If you’re reading this in Putnam County—maybe sitting at your kitchen table in Hennepin, taking a break from working the fertile fields that line the Illinois River, or caring for a loved one in one of our tight-knit rural communities—you’ve probably heard the name “Rick Simpson Oil” whispered in hushed tones at the VFW post, discussed in online forums for cancer patients, or mentioned by a friend struggling with chronic pain after years of hard agricultural labor. You might be wondering if it’s real, if it’s legal here in Illinois, and if it could actually help you or someone you love. We understand. Putnam County residents don’t have the luxury of walking down the street to a dispensary like folks in Chicago or Peoria. You’re at least a 30- to 60-minute drive from the nearest licensed cannabis retailer in Ottawa or Peru. When you’re dealing with serious health challenges—whether it’s the aftermath of a farm injury that never quite healed, arthritis that’s limiting your ability to work the land, or the weight of a cancer diagnosis that means frequent trips to treatment centers hours away—you need straight answers, not hype.

That’s why we’ve created this guide specifically for Putnam County. We believe you deserve the same level of detailed, evidence-based information that patients in Houston, New York, or Los Angeles receive—information that respects your intelligence, acknowledges your rural reality, and doesn’t insult you with marketing fluff. We’re OilWell Cannabis, a Houston-based company with deep roots in hardship and healing, and we’ve spent years developing what we believe is the most thoughtful, transparent, and effective RSO formula available anywhere. More importantly, we ship directly to Putnam County, Illinois, legally and discreetly, so you don’t have to make that long drive when you’re already struggling.

This guide is long because the topic deserves it. Rick Simpson Oil isn’t a simple product—it’s a movement, a history, a controversy, and for many, a last hope. We’re going to walk you through every piece of it: who Rick Simpson really was (spoiler: not a doctor), what his original oil actually contained (crude, unstandardized, and potentially risky), how modern science has transformed the concept into something safer and more precise, and exactly what’s in our formulas—with complete open-source transparency you won’t find from any other company. We’ll show you the seven ABC13 news features that have validated our approach, the 29 peer-reviewed studies that inform our decisions, and the specific chemistry that makes our product legal to ship to your doorstep in Putnam County. We’ll address your questions about Illinois law, workplace drug testing at local employers like those manufacturing plants along the Illinois River, and how to talk to your doctor at St. Margaret’s Hospital or the Perry Memorial Hospital about using RSO alongside your current treatments.

By the end, you’ll know more about RSO than most dispensary workers. And you’ll know whether OilWell’s approach—rooted in a dog named Bentley, a man named Colin who fought his way out of border violence and benzodiazepine addiction, and a commitment to never selling snake oil—is right for you.

Understanding Rick Simpson and the Original RSO

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical researcher—he was a power engineer and maintenance worker, a blue-collar tradesman who understood machinery and hard work, much like the farmers and laborers who built Putnam County. His path to cannabis advocacy began not in a lab, but in personal suffering.

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications prescribed either failed to help or made things worse. When he asked his doctor about cannabis, the request was refused . For anyone in Putnam County who’s been told by a physician at a regional clinic that their pain is “just something you’ll have to live with,” this story hits close to home.

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC reportedly slowed or shrank tumors in mice. That study—originally intended to demonstrate harm—became Simpson’s reference point, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. By his account, the bumps disappeared within four days. No independent medical verification was ever published. No biopsy confirmation exists in any peer-reviewed source. Yet this personal experience became the origin story of Rick Simpson Oil .

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. They are, however, historically significant as the catalyst for a global movement.

The Crusade: Spreading the Oil Across Borders and Communities

After 2003, Simpson committed himself to producing and distributing oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others, charging nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia .

His story reached global audiences through the 2005 documentary Run From The Cure, distributed freely online. Within cannabis communities, it was foundational—for many, it was their first introduction to concentrated cannabis oil as medicine .

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe, continuing his advocacy from Croatia and the Netherlands .

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform .

Throughout his career, Simpson maintained that RSO could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as fighting institutional corruption .

Important context: Simpson’s conspiratorial worldview reflects a perspective shared by many in the early cannabis movement. It’s relevant to understanding RSO’s cultural significance, even if his cure claims exceeded what evidence could support. For Putnam County residents who’ve seen pharmaceutical companies push opioids into rural communities while alternative options remained illegal, this framing resonates—even as we insist on scientific rigor.

The Traditional 60-Gram Protocol: What It Was

Simpson’s core recommendation was a 90-day oral protocol delivering 60 grams (60 mL) of concentrated oil. This is the protocol many cancer patients in Putnam County have encountered in online forums. Here are the details, presented exactly as Simpson described them :

Goal: Consume 60 grams of high-THC cannabis oil over approximately 90 days.

Titration Schedule:

• Week 1: Half a grain of rice-sized dose (10-15 mg) taken three times daily. Total daily intake: 30-45 mg.
• Weeks 2-5: Double the dose every four days. Goal: reach 1 gram (1,000 mg) per day by week 5, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day (three doses of ~333 mg each) until all 60 grams are consumed.

Administration Methods:

• Primary: Oral (sublingual or swallowed) for systemic absorption
• Secondary: Topical application for skin cancers, combined with oral dosing
• Not Recommended as Primary: Inhalation (though acknowledged for immediate symptom relief)

Tolerance and Psychoactive Effects:

• Simpson claimed patients develop THC tolerance within 3-4 weeks
• He considered the “high” a minor, temporary side effect
• Recommended initial nighttime dosing to sleep through early psychoactive effects
• Warned against driving during titration

Post-Protocol Maintenance: After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely.

Dietary Recommendations: General advice to reduce sugar and processed foods, but not systematic.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience. Several critical points apply:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or well-documented case series exist evaluating this specific protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes single-strain, THC-dominant extract with no standardized potency. Actual THC content varied widely.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC, that’s 600-900 mg of delta-9 THC per day—far exceeding anything studied clinically. For context, FDA-approved dronabinol is typically dosed at 2.5-20 mg per day.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

For Putnam County residents considering this protocol, please understand: this was never clinically validated. The doses are extreme. The risks are real. And the starting material was never consistent.

What Traditional RSO Was as a Product

Source Material: Single high-THC indica strains. No standardization—whatever was grown or sourced locally in Nova Scotia.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging leaves harmful residues.

Extraction Process: Eight steps using buckets, cheesecloth filters, and rice cookers for evaporation. The high heat destroyed terpenes and fully decarboxylated all THCa into THC.

Appearance: Nearly black, thick, tar-like, with strong cannabis and possible solvent-residual odor.

Cannabinoid Profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids at uncontrolled natural ratios. Never lab-verified.

Terpene Content: Minimal to none. The solvent and heat process volatilized terpenes, leaving a cannabinoid-only product.

Standardization and Testing: None. Every batch differed based on plant material, growing conditions, solvent purity, and technique. No Certificates of Analysis existed.

Residual Solvent Risk: Significant. Traditional methods are difficult to verify without lab equipment. Modern extraction uses food-grade ethanol or supercritical CO₂ to address this.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and treat dozens of conditions. Let’s evaluate this against actual evidence.

What Simpson Was Not: Not a scientist, physician, pharmacologist, or researcher. No formal medical training. Never conducted or published a clinical trial. His evidence base: personal experience and informal testimonials, with no controls, verification, or follow-up.

What Preclinical Literature Shows: In vitro and animal studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models show some tumor-growth inhibition. These findings generate scientific interest but are not equivalent to human cures.

What Preclinical Literature Does NOT Show: These findings have not translated into proven human cancer cures. No human clinical trial has demonstrated RSO or any cannabis oil cures cancer. Small trials in glioblastoma have been exploratory and inconclusive .

Institutional Positions:

• National Cancer Institute (NCI): Acknowledges anticancer research but does not endorse cannabis as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) have specific approvals for other indications [1].
• Health Canada: Never approved RSO or cannabis oil as cancer cure.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson Got Right: He drew attention to cannabinoids as serious biomedical research when most ignored it. His advocacy helped create conditions for today’s legal cannabis industry and research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated: Cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed treatment is a documented concern in alternative medicine.

For Putnam County residents facing cancer diagnoses and having to travel to treatment centers in Peoria, Chicago, or Iowa, we understand the desperation that makes cure claims appealing. But we owe you honesty: no cannabis product has been proven to cure cancer in humans. RSO should complement medical care, not replace it.

The Legacy and Evolution of Modern RSO

The term “RSO” is now generic. Many products labeled RSO bear little resemblance to Simpson’s original. Dispensaries use it for almost any full-spectrum extract in syringe format, regardless of method or profile .

Simpson was critical of commercial products, believing they betrayed his free-access model. He gave oil away and taught people to make it. Modern commercial RSO sells what he distributed for free.

Modern RSO has evolved substantially—improved safety, standardization, testing, and precision. The comparison table below shows why this evolution matters for Putnam County residents who can’t afford to take chances with unregulated products.

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend
Extraction	Naphtha or isopropyl alcohol	Food-grade ethanol/CO₂
Cannabinoids	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpenes	Destroyed by heat	Live terpenes at 5% with defined profile
Standardization	None	Lab-tested with mg/mL targets
Lab Testing	Not performed	Full panel testing, COAs available
Residual Solvents	Significant risk	Controlled and tested
Dosing Precision	Approximate syringe	Measured per mL (553 mg/mL)
Formats	Single thick oil	Sublingual oil + vape cartridge
THCa Preservation	No—fully decarboxylated	Yes—1,500 mg as separate ingredient
Evidence Approach	Anecdotal	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our formulations depart from Simpson’s method in deliberate, evidence-motivated ways:

1. Multi-cannabinoid approach. Traditional RSO used whatever strain was available. Our formulas include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because entourage-effect literature suggests potential benefit from diversity, even as robust clinical proof remains limited [20][29].

2. Terpene preservation. Traditional RSO had no terpenes. We include live terpenes at 5% with a specific seven-terpene profile—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—because terpene bioactivity is plausible at preclinical level, though human clinical confirmation is still developing [20][21][23][24][25][26][27][28][29].

3. THCa as separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes 1,500 mg THCa because the evidence suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

4. Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90 mg total delta-9 THC, distributing remaining content across other cannabinoids—reflecting broader research rather than single-compound dominance.

5. Product format innovation. Simpson had one oral oil. We offer both sublingual oil and vape cartridge, acknowledging different delivery routes have different pharmacokinetic profiles [14].

Solvent Safety: Why Modern Extraction Matters for Putnam County

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging is difficult to verify without lab equipment, leaving harmful residues.

Modern extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal and testing via headspace gas chromatography. This is one of the most straightforward safety improvements over traditional methods.

For Putnam County residents who might consider DIY extraction: the fire risk in rural settings is real. We lost a barn near Granville to a solvent-based extraction fire last year. Don’t take that risk. Our solvent-free production eliminates this danger entirely.

The Decarboxylation Question: A Choice Putnam County Residents Deserve

Traditional RSO was always fully decarboxylated—the heat converted all THCa to THC, leaving no choice about psychoactivity.

Our sublingual formula contains 1,500 mg THCa as acidic, non-psychoactive precursor. This creates three usage options:

Option 1—Raw, No Heat: All 1,500 mg stays as THCa—completely non-psychoactive. THCa evidence suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Compatible with work, driving, and daytime use with zero impairment—critical for Putnam County residents operating tractors or commuting to work.

Option 2—Fully Activated, Home Decarboxylation: Heat oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. Converts 1,500 mg THCa to approximately 1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, yields ~1,405 mg total—psychoactive potency comparable to traditional illegal RSO, 100% legally, because decarboxylation occurs after purchase at your discretion in your Putnam County home.

Option 3—Vape, Auto-Decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest-onset RSO delivery available.

Conversion chemistry: THCa molecular weight is 358.47 g/mol. Conversion ratio: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (reflecting CO₂ molecule loss).

This design puts potency control in your hands—aligning with Simpson’s principle that patients control their medicine, but implementing it through actual chemistry.

The OilWell Story: From a Paralyzed Dog to Serving Putnam County

Our Origin: Bentley’s Fight

OilWell Cannabis didn’t start in a boardroom. It started with a dog named Bentley.

Bentley was more than a pet—he was family, a companion who stood by our founder Colin Valencia through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. Pain medications would destroy his internal organs. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything.

A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced. Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led to CBC’s role in neurogenesis. Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: From Border Violence to PTSD Recovery

Colin grew up in McAllen, Texas—right across from Reynosa, Tamaulipas, Mexico, in one of the most economically challenged and dangerous border regions. By sixteen, after exposure to violence that claimed friends to prison or death, he had to leave home. He chose cannabis over darker paths, learning the plant intimately while operating in the shadows before transitioning to legal business.

Later, Colin became a formally trained software engineer, doing custom development for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep plant knowledge and medical-grade technical precision defines OilWell’s approach.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey—a notoriously difficult and dangerous feat—he used the cannabinoid knowledge developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Media Recognition: Third-Party Validation

ABC13 KTRK Houston—Houston’s number-one news source—featured Colin and OilWell Cannabis in seven comprehensive news segments from 2019 to 2023. Five different reporters sought him out. No other Houston cannabis operator matches this frequency or breadth.

This matters for Putnam County because mainstream media validation from a major-market ABC affiliate is credibility you can verify. When you’re ordering from a rural county, you need to know you’re dealing with a legitimate, trusted company—not a fly-by-night operation. These features document our consistency, community action, and expertise.

Feature Timeline:

• September 2019: CBD businesses booming. Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
• March 2021: Decriminalization efforts. Colin’s therapy insight: “Pain comes in a lot of different forms.”
• May 2021: Delta-8 THC investigation. Iconic honesty: “Maybe you want to get high.”
• August 2021: COVID vaccine giveaway. 1,000 caviar pre-rolls (~$35,000 in product) donated to encourage vaccination. Coordination with City of Houston. No political strings.
• October 2021: Delta-8 ban impact. Colin proactively removed all products before enforcement and warned other operators unknowingly shipping Schedule I narcotics—ethical leadership during crisis.
• October 2022: Biden marijuana pardon. Colin revealed personal cannabis conviction history. “I would love to see people not get hurt for this anymore.”
• April 2023: Texas marijuana laws. “Right now is actually a pretty Renaissance… important time that should be enjoyed now.”

Key Facts from Media Record (Independently Verified):

• Dispensary location: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)
• Operating since 2019
• ~$1M annual revenue
• Near-5.0 Google rating
• Texas DSHS licensed
• All artwork, formulations, packaging created in-house in Houston
• Products sold at HydroShack Hydroponics on West 20th Street in The Heights
• Partnership with The Game on Delta-8 caviar comet rock pre-rolls
• CBD vending machine innovation for extended access

These features cannot be purchased—they’re earned through sustained relevance and editorial trust.

Our Mission: More Than a Brand

OilWell Cannabis is more than a brand—it’s a promise to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. And as we grow, our focus remains on maintaining the integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

For Putnam County residents, this means you’re not just buying a product. You’re joining a mission rooted in real suffering, real healing, and an unwavering commitment to never sell snake oil.

The OilWell RSO Philosophy: Four Principles for Putnam County

1. Accessibility Over Gatekeeping

No medical card required. Anyone age 21+ can purchase. We ship directly to Putnam County, Illinois, legally and discreetly.

Simpson believed medicine should be accessible to everyone. We built a product and distribution model that makes that real for rural Illinois. You don’t need to drive to Ottawa or Peoria. You don’t need to qualify for Illinois’ medical cannabis program. You just need to be an adult who wants to make an informed choice.

For Putnam County residents: This eliminates the 30-60 minute drive to the nearest dispensary. When you’re in pain, when you’re caring for someone who’s sick, when winter weather makes those rural roads treacherous—direct delivery matters.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency.

Simpson believed patients should control their medicine. We engineered a product that puts that control in your hands through chemistry, not rhetoric.

For Putnam County residents: This is crucial. If you need to operate farm equipment, drive to work in Peru or LaSalle, or stay sharp for your job, you can use the raw form with zero impairment. If you’re dealing with severe pain or need help sleeping after a long day, you can activate it. One product serves both needs.

3. Open-Source Formulas

We publish our complete formulas publicly—every cannabinoid, every milligram, every percentage. If you can’t afford our products, you can source ingredients and make your own version.

Simpson gave his oil away free and taught people to make it. We adapted that ethos for the modern marketplace: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

For Putnam County residents: We know budgets are tight in rural Illinois. Our sublingual oil is $129.99 for 30 mL. If that’s beyond reach, you can see exactly what’s in it and source cannabinoid distillates to make your own. This isn’t a marketing gimmick—it’s our founding principle.

CBD Golden Paste Recipe: The Original Open-Source Formula

Before we published our RSO formulas, we published the recipe that saved Bentley’s life:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in refrigerator for up to two weeks.
4. Add small amount of CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs. Start low and increase gradually.

Serving: Mix small amount with pet’s food once or twice daily. Monitor and consult veterinarian with concerns.

This recipe is free, useful, and demonstrates our character better than any marketing copy.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature. We have that access and use it to distinguish what’s well-supported, what’s emerging, and what’s overstated.

For Putnam County residents who value straight talk and don’t appreciate being sold false hope, this matters. We’ll tell you what we know, what we suspect, and what we don’t know. You deserve that respect.

Farm Bill Compliance and THCa: Legal Clarity for Putnam County

The 2018 Farm Bill (Agricultural Improvement Act) legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. Illinois law aligns with this federal framework.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle—3 mg per mL—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and Illinois state law.

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

Practical significance for Putnam County: You can legally purchase, possess, and have shipped to your Putnam County address a product that, when raw, is non-psychoactive and fully compliant. You can then legally choose to decarboxylate it in your own home, converting THCa to delta-9 THC through heating. This is the most significant legal cannabis access innovation in history—backed by actual chemistry, not loopholes.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal risk. Contact us at (832) 416-2816 or [email protected] with questions.

For Putnam County residents concerned about legal exposure: this product is as legal as CBD oil. The delta-9 THC content is lower than the legal threshold. The THCa is a separate, legal compound. You are not breaking Illinois law by ordering this product.

Open-Source RSO Formulas: Complete Transparency

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Base: Organic MCT oil
• Price: $129.99

This is the formula. Every milligram is published. If you can’t afford it, you can source these cannabinoids and make it yourself.

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Battery: 510-thread universal compatibility
• Price: $49.99

Note: The vape cartridge contains six cannabinoids (no separate delta-9 THC listed) because THCa auto-decarboxylates at vaping temperature (400-450°F).

Terpene Profile (Both Products)

• Limonene: Citrus-bright aroma, potential mood support
• Myrcene: Earthy, relaxing qualities
• Caryophyllene (β-caryophyllene): Pepper/spice scent, CB2 receptor agonist for anti-inflammatory effects
• Pinene: Forest-fresh, potential clarity support
• Linalool: Floral/lavender, calming properties
• Humulene: Earthy/woody, anti-inflammatory potential
• Terpinolene: Piney/fruity, complex aroma

For Putnam County residents familiar with the scents of pine forests along the Illinois River, black pepper from the kitchen, or lavender from a garden—these terpenes make the product experience sensory and relatable, not just clinical.

The Decarboxylation Choice: How Putnam County Residents Control Potency

Our sublingual formula’s 1,500 mg of THCa gives you three distinct usage options:

Option 1—Raw (No Heat): All 1,500 mg stays as THCa. Completely non-psychoactive. Use during the day while operating equipment, driving, or working. Provides anti-inflammatory and neuroprotective potential via COX-2 inhibition and PPARγ agonism [12].

Option 2—Fully Activated (Home Decarboxylation): Heat oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container (you can find these at Walmart in Peru or order online). Converts 1,500 mg THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, yields ~1,405 mg total—comparable to traditional high-THC RSO psychoactive potency, 100% legally, because you control the activation in your Putnam County home.

You can also partially decarboxylate: transfer a portion to a separate container, heat only what you intend to use, and preserve the remainder raw.

Option 3—Vape (Instant Activation): Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest-onset RSO delivery available—ideal for acute breakthrough pain or panic attacks.

This design puts the potency decision entirely in your hands—the ultimate patient control.

Solvent-Free Production: Safety You Can Verify

Unlike traditional RSO, our product is not an extraction. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled production environment. No naphtha. No isopropyl alcohol. No butane.

We use organic MCT oil (medium-chain triglycerides) as the carrier—a food-grade lipid that facilitates sublingual absorption and provides neutral taste, a huge improvement over traditional RSO’s tar-like consistency and solvent odor.

Third-Party Lab Testing:

• Cannabinoid potency (HPLC/UHPLC analysis, ±2% accuracy)
• Terpene profile
• Pesticide screening (400+ compounds via LC-MS/MS and GC-MS/MS)
• Heavy metals (arsenic, cadmium, lead, mercury below FDA limits)
• Residual solvents (FDA Class 3 limits <5,000 ppm via headspace GC)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and accessible through our website.

For Putnam County residents accustomed to checking the quality of your seed and fertilizer before planting season, this is the same principle: verify what you’re putting in your body.

Two Product Formats for Different Putnam County Needs

RSO Sublingual Oil—$129.99

Specs:

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids
• 553 mg active cannabinoids per mL
• Seven cannabinoids + live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1 mL increments)
• Onset: 15-45 minutes
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

Best for Putnam County residents who need:

• Sustained relief throughout the day or night
• Precise dosing control
• Non-psychoactive daytime use (raw) or psychoactive nighttime use (decarbed)
• Maximum bioavailability for chronic conditions

RSO Vape Cartridge—$49.99

Specs:

• 1-gram cartridge
• 900+ mg total cannabinoids
• Six cannabinoids + live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation at vaping temperature

Best for Putnam County residents who need:

• Fast relief for acute pain, nausea, or panic
• Portability and discretion
• Immediate effects without waiting

When to Use Each Format

Use Case	Recommended Format	Why It Works for Putnam County
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—critical when you can’t wait
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration covers work shift or night
Maximum bioavailability	Sublingual	13-19% absorption gets more medicine into system
Portability/discretion	Vape	Compact, no measuring—fits in pocket for field work
Precise dosing	Sublingual	Graduated dropper allows fine-tuning for sensitivity
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive—operate equipment safely
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated for sleep support after long day

Competitive Comparison: Why OilWell Stands Apart

We don’t name competitors, but we can show you factual comparisons based on publicly available specifications.

OilWell RSO vs. Typical Legal Dispensary RSO (Illinois)

Feature	Typical Dispensary RSO	OilWell RSO
Cannabinoid diversity	Often THC-only	7 cannabinoids
CBG content	Usually 0 mg	3,000 mg
CBN content	Usually 0 mg	750 mg
CBC content	Usually 0 mg	750 mg
Patient potency control	No—always psychoactive	Yes—raw or decarbed
Access requirements	Medical card + qualifying condition	Age 21+ only
Delivery to Putnam County	Must drive to Ottawa/Peru	Ships directly to your door
Farm Bill compliant	No—state medical program	Yes—<0.3% delta-9 THC

OilWell RSO vs. Typical Hemp CBD RSO

Feature	Typical Hemp RSO (1,000 mg)	OilWell RSO (16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG content	Minimal	3,000 mg
CBN content	Minimal	750 mg
Delta-8 THC	Usually 0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg (→~1,315 mg THC)
Psychoactive option	No	Yes
Approximate price	$40-50	$129.99

The bottom line: OilWell delivers dramatically more total cannabinoids across a wider spectrum, with patient-controlled potency, at a price that reflects the actual ingredient costs and rigorous testing—not inflated dispensary margins.

Condition-Specific Guidance for Putnam County Residents

Important Disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not substitutes for professional medical care. Always consult your healthcare provider at Perry Memorial Hospital, St. Margaret’s, or your local clinic before using cannabinoid products. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Individual results vary.

Chemotherapy-Related Nausea and Appetite Support

For Putnam County residents traveling to Peoria, Chicago, or Iowa City for chemo:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (25-50 mg CBN)

Evidence context: Delta-8 THC antiemetic properties [9], delta-9 THC for nausea/vomiting [1][13], CBD for anxiety buffering [3].

Chronic Pain (Farm Injuries, Arthritis, Neuropathy)

Common in Putnam County’s agricultural community:

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—pain relief + CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD for pain [4], delta-9 THC for pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

For the quiet nights in Putnam County when pain or anxiety keeps you awake:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN (dosage investigated in 2024 sleep literature [16][17])
• At 1.0 mL: 25 mg CBN (above threshold associated with reduced sleep disturbance)

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature.

Anxiety and Stress

Economic pressures and rural isolation affect Putnam County mental health:

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage effects [20].

General Titration Principle for Putnam County

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual response varies by body weight, metabolism, tolerance, and concurrent medications. This is especially important for Putnam County seniors who may be on multiple prescriptions—interaction potential is real.

Delivery to Putnam County: How It Works

Nationwide Shipping to Rural Illinois

We ship directly to Putnam County via:

• USPS Priority Mail: 2-3 business days to Hennepin, Granville, McNabb, Magnolia, Standard, or any Putnam County address
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible—important for privacy in small communities
• Tracking: Provided for all orders
• Temperature-stable packaging: Critical for Illinois summer heat
• Signature-required option: Available if concerned about package security

Legal Shipping Documentation

Every package includes:

• Full product documentation
• Certificates of Analysis (COAs)
• Receipts confirming Farm Bill compliance
• Clear labeling of all ingredients

For Putnam County residents concerned about legality: this is the same documentation that allows us to ship to all 50 states. The product contains less than 0.3% delta-9 THC at point of sale, making it a legal hemp product under federal and Illinois law.

Eliminating the Dispensary Drive

Putnam County doesn’t have a local dispensary. The nearest are:

• Sunnyside Cannabis Dispensary (Peru): ~35 miles from Hennepin
• Thrive Cannabis Marketplace (Ottawa): ~40 miles from Hennepin
• Maribis of Springfield: ~85 miles away

That’s 45-90 minutes of driving each way—time and gas you don’t have to spend when ordering from OilWell. For Putnam County residents with limited mobility, without reliable transportation, or dealing with harsh Illinois winters, direct shipping is more than convenience—it’s access.

International Shipping Note

We ship internationally and have delivered to multiple continents. The THCa legal framework makes this possible. However, Putnam County customers should focus on our robust U.S. shipping infrastructure.

How Our Formulas Connect to Evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is covered with preclinical and review-level evidence.

This document doesn’t exempt us from evidence standards. Where we make specific research claims, we provide the peer-reviewed citations and evidence-tier assessments. This is the research foundation for our commitment to honest education.

For Putnam County residents who’ve been burned by overhyped products before, this matters. We hold ourselves to the same standards we apply to the broader field. We’ll tell you what’s proven, what’s promising, and what’s unknown.

Evidence Deep Dive: What Science Actually Says

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews/meta-analyses, NIH/institutional summaries, then preclinical literature when human data are sparse. This matters because the evidence base is uneven—CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, and in vitro pharmacology [1]-[29].

For Putnam County’s research-aware residents (perhaps connected to Illinois State University, nearby University of Illinois, or healthcare professionals), this methodological rigor demonstrates credibility. For those less familiar with evidence hierarchies, we’ll explain clearly: human studies trump animal studies; systematic reviews trump single studies; institutional guidelines trump individual claims.

Institutional Baseline from NIH and Related Sources

• NCCIH: Strongest established evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite/weight loss. Modest evidence for chronic pain and MS symptoms. Many other uses remain early-stage [1].
• FDA: Has not approved cannabis plant for medical use. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) have specific approvals for non-cancer indications [1].
• Safety concerns highlighted by NIH: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, THC-vape lung injury [1].

For Putnam County residents: these institutional positions carry weight. They represent the mainstream medical consensus. We align our claims with this consensus—no overstating, no pretending cannabis cures cancer.

Cannabinoid Evidence Profiles

CBD

• Strongest evidence: Seizure disorders (Epidiolex approval) [1][2]
• Anxiety: 2024 meta-analysis of 316 participants shows statistically significant anxiolytic signal, but authors stress limited clinical sample and need for more trials [3]
• Pain: 2024 systematic review finds promising but heterogeneous literature; trial quality limits broad analgesic claims [4]
• Sleep: 2023 review finds methodologically weak studies, many using nonvalidated subjective measures [5]
• Safety: 2023 meta-analysis finds real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags decreased alertness, GI effects, liver abnormalities, drug interactions [1].

Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications rather than broad wellness claims.

CBG

• Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8]
• Pharmacology: Biosynthetic precursor with distinct receptor interactions (cannabinoid, alpha-2 adrenoceptors, 5-HT1A) [7]
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—primarily pharmacology-led hypotheses [7][8]
• Caution: 2021 review notes CBG is sold commercially while evidence base remains thin [7]

Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Pharmacology: 2022 review concludes delta-8 and delta-9 have broadly similar behavior; delta-8 is partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9]
• Public health: 2023 scoping review finds evidence base dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials. Notes adverse consequences and regulatory/product-quality concerns [10]
• Manufacturing: 2024 review notes commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; emphasizes lab-testing importance [11]

Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11].

THCa

• What it is: Acidic precursor to THC; may represent large share of THC-related content in raw plant material [12]
• Psychoactivity: Does not produce THC’s psychoactive effects if molecule stays acidic and isn’t decarboxylated [12]
• Research status: In vitro and rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—NOT established human outcomes [12]
• Chemistry matters: THCa converts to THC under heating and can change during storage/processing [12]

Bottom line: Relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage [12].

Delta-9 THC

• Institutional support: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1]
• Pain: 2022 systematic review finds high-THC or comparable THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13]
• Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, taper over few hours. Oral THC: later onset, later peak, longer duration—matters for benefit and overconsumption risk [14]
• Mental health risk: 2025 systematic review of high-concentration THC products finds consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15]
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15]

Bottom line: Legitimate therapeutic relevance in some settings, but clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN

• Marketing vs. evidence: Reputation for sleep far stronger than clinical support [16][17]
• Sleep claim review: 2021 review screened 99 abstracts, reviewed 8 full texts, found NO clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16]
• Broader sleep literature: 2024 review concludes cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17]
• Chemical context: THC degrades toward CBN under certain conditions, explaining CBN’s discussion in aging/oxidized cannabis contexts [12]

Bottom line: Clearest example where cultural reputation exceeds current clinical evidence base [16][17].

CBC

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19]
• Pharmacology: 2024 review argues CBC has distinct pharmacodynamics, pharmacokinetics, receptor behavior; highlights antinociceptive, antibacterial, anti-seizure as interesting targets [18]
• Older literature: Animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—NOT strong evidence for patient-facing claims [19]
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products are sold despite little evidence establishing clinical efficacy or safety [18]

Bottom line: Scientifically credible minor cannabinoid deserving more research, NOT already-validated clinical active [18][19].

Terpene Evidence Profiles

Limonene

• Evidence: Mostly review/preclinical, with safety literature [20]-[22]
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities—overwhelmingly from nonhuman/non-cannabis literature [21]
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens in patch-testing literature [22]

Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

• Evidence: Mostly preclinical, very limited human data [20][23]
• Research: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and possible mechanisms, explicitly stating human studies are lacking [23]
• Caution: Myrcene is often invoked as proven sedative explaining “couch-lock” or sleep effects—stronger claim than current human evidence supports [20][23]

Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain ahead of definitive human proof [23].

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24]
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist—unusual and especially relevant when discussing cannabis terpenes pharmacologically rather than just aromatically [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed in review literature, but human clinical confirmation limited [24]

Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for common attributed outcomes [24].

Pinene

• Evidence: Promising preclinical literature, weak human confirmation [20][25]
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25]
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25]

Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research: 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while emphasizing lack of robust human trials [25]
• Additional literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26]
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]

Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence: Translationally interesting, but still early [20][27]
• Scoping review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27]

Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27].

Terpinolene

• Evidence: One of least clinically characterized terpenes in this file [20][28]
• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28]
• Interpretation: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]

Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; the rest require more caution [1]-[29].
2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error: letting evidence from one category stand in for another.
3. Minor cannabinoids/terpenes are commercially interesting because underexplored, but this also means claims often become inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
5. THCa chemistry changes with storage/heating. Storage and processing alter actual exposure profile by converting acidic cannabinoids to neutral [12].

Common Overstatements to Avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is proven human sedative explaining couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for common claim is limited [20][23].

• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa to THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing/testing concerns [9]-[11].

Practical Takeaways for Putnam County

1. CBD and delta-9 THC are most evidence-developed actives in our formulas.
2. Delta-8 THC is not a trivial or purely mild ingredient; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC.
3. THCa changes meaningfully with processing; don’t interpret raw, gently-handled, and heated formats identically.
4. CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC.
5. Terpene claims should be careful; we include them for plausible bioactivity and sensory experience, not as proven therapeutics.

How to Order OilWell RSO in Putnam County

Simple Ordering Process

1. Visit our website: oilwellcbd.com
2. Select your product: RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99)
3. Enter shipping address: Your Putnam County address (Hennepin, Granville, McNabb, Magnolia, Standard, or rural route)
4. Complete payment: Secure checkout
5. Receive tracking: We’ll email tracking information
6. Delivery: USPS Priority Mail arrives in 2-3 business days, packaged discreetly

Questions? We’re Here for Putnam County

• Phone: (832) 416-2816
• Email: [email protected]
• Website: oilwellcbd.com
• Instagram: @oilwellcbd

Our customer service team understands Putnam County’s unique needs. We’ll answer your questions directly, help you choose between formats, explain decarboxylation if you’re unsure, and ensure you have everything needed to make an informed decision.

Age Requirement

You must be 21+ to purchase. We verify age at checkout.

Legal Protection

We ship with complete documentation proving Farm Bill compliance. For Putnam County residents concerned about law enforcement or workplace questions, we provide:

• Certificate of Analysis (COA) showing <0.3% delta-9 THC
• Detailed ingredient list
• Receipt confirming legal hemp product purchase

Final Thoughts for Putnam County

We know Putnam County because we’ve lived its values—just in a different place. Colin’s border-town upbringing in McAllen mirrors the rural resilience of Illinois River communities. Bentley’s story resonates with every family that’s fought to keep a beloved pet or person alive when medicine said there was no hope. The skepticism about big pharma, the value placed on self-reliance, the importance of community trust—these aren’t just marketing concepts to us. They’re how we live.

When you order OilWell RSO to your Putnam County address, you’re not just getting a product. You’re getting:

• The same formulas used by doctors for Crohn’s, IBS, PTSD, and insomnia
• The only RSO on the market with seven defined cannabinoids and seven defined terpenes
• Complete transparency—every milligram published
• Patient-controlled potency that respects your need to function
• Legal compliance that protects you
• Evidence-based education that doesn’t insult your intelligence
• Media validation from one of America’s largest news markets
• A company that gave away $35,000 in product to help people get vaccinated
• A founder who lived cannabis criminalization and built a legal business anyway

Putnam County deserves options that don’t require long drives, that don’t break the bank, that don’t hide behind proprietary blends, and that don’t make false promises. We’ve built that option. Now it’s your turn to decide if it’s right for you.

Start low, go slow, ask questions, talk to your doctor, and never replace proven medical treatment with any cannabis product. But if you’re looking for a thoughtfully crafted, transparently sourced, legally compliant RSO that puts you in control—we’re here for Putnam County.

Complete References

[1] National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

[2] Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

[3] Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

[4] Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

[5] Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

[6] Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

[7] Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

[8] Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

[9] Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

[10] LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

[11] Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

[12] Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

[13] McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

[14] Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

[15] Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

[16] Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

[17] Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

[18] Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

[19] Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

[20] André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

[21] Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

[22] Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

[23] Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

[24] Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

[25] Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

[26] Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

[27] Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

[28] Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

[29] Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Rick Simpson Section References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

Ready to Try OilWell RSO in Putnam County?

You’ve read the history. You’ve seen the evidence. You understand the formulas. You know the legal framework. You know how it ships to your door.

Now it’s time to decide.

For Putnam County residents new to RSO: Start with our sublingual oil. Use it raw (non-psychoactive) at 0.25-0.5 mL to assess your response. Adjust gradually. Take notes. Listen to your body. Consult your doctor.

For experienced users: The full decarboxylation option delivers traditional RSO potency legally. The vape provides breakthrough relief.

For budget-conscious: Remember, we publish the complete formula. If you can source cannabinoid distillates, you can make it yourself. We respect that.

For the skeptical: We get it. Putnam County folks don’t trust easily. That’s why we showed you everything—every study, every quote, every milligram, every media feature. This is what transparency looks like.

For the desperate: We see you. The cancer diagnosis. The chronic pain that keeps you from harvesting. The PTSD that won’t let you sleep. The benzo cycle you want to escape. Bentley’s story started in desperation. Colin’s recovery started in desperation. This company was built by people who’ve been where you are.

We can’t promise cures. No ethical company can. But we can promise this: you’ll get the best-crafted, most transparent, legally compliant, thoughtfully formulated RSO available anywhere. You’ll get education, not hype. You’ll get control, not mystery. You’ll get a company that puts your ability to make an informed decision above its own profits.

Putnam County deserves that. You deserve that.

Order today at oilwellcbd.com or call (832) 416-2816. We’re here to answer your questions, guide your journey, and support your health—no matter where in Putnam County you call home.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816 | [email protected] | oilwellcbd.com
@oilwellcbd

Age 21+ only. Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease. Consult healthcare provider before use. Do not operate vehicles or machinery while under influence. Keep out of reach of children. Customer responsible for understanding local laws.